Home » GSK, Roche Breast-Cancer Treatments Work Better Combined, Study Shows
GSK, Roche Breast-Cancer Treatments Work Better Combined, Study Shows
Combining GlaxoSmithKline’s Tykerb drug with Roche Holding’s Herceptin to treat breast cancer was almost twice as effective as single-drug therapy, according to researchers in a 23-country clinical trial.
Bloomberg
Bloomberg
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May